CD177 and Stroke: For example, many intracellular and extracellular mediators of MCs activation, cell-surface receptors involved in mastocytic modulation, and molecules released by activated MCs can be targeted by different molecules with potential beneficial effects in therapeutic intervention against stroke (for novel approaches in clinical targeting of MCs functions see [37,208]).